Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP report no. 3
- 1 April 2004
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 137 (4) , 683-696
- https://doi.org/10.1016/j.ajo.2003.11.059
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSESRetina, 2002
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey1Ophthalmology, 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999